Jennifer Malin, MD, medical director for oncology at Anthem, explains how both physicians and payers struggle with the high cost of some cancer treatment drugs.
Jennifer Malin, MD, medical director for oncology at Anthem, believes that both physicians and payers struggle with the high cost of some cancer treatment drugs, which is a large part of what medical oncology focuses on.
She says it’s hard to weigh the high cost of the therapy in a manner that doesn’t put the risk on the physician.
“I think that’s the challenge, trying to figure out how to support the care of these complex patients, not incentivizing use of expensive therapies that aren’t going to improve outcomes but also not putting physicians at risk for a $10,000 a month therapy,” Dr Malin says.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More